Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Carme Salvador García"'
Autor:
Juan Vicente Mulet Bayona, Carme Salvador García, Nuria Tormo Palop, Amparo Valentín Martín, Carmelo González Padrón, Javier Colomina Rodríguez, Javier Pemán, Concepción Gimeno Cardona
Publikováno v:
Journal of Fungi, Vol 8, Iss 3, p 281 (2022)
Epidemiological trends show a dramatic increase in the prevalence of fungal infections, and in the isolation of multidrug-resistant species, such as Candida auris. CHROMagarTM Candida (CC; CHROMagar, Paris, France) and other chromogenic media, which
Externí odkaz:
https://doaj.org/article/571cf77a24f145d195295ae89b7ef3d0
Autor:
Juan Vicente Mulet Bayona, Nuria Tormo Palop, Carme Salvador García, Begoña Fuster Escrivá, Mercedes Chanzá Aviñó, Pilar Ortega García, Concepción Gimeno Cardona
Publikováno v:
Journal of Fungi, Vol 7, Iss 6, p 440 (2021)
In addition to the increase in fungal infections that has been observed in the last few decades, it has been reported that severe clinical COVID-19 can increase the risk of invasive fungal infections. The main objective of this study was to evaluate
Externí odkaz:
https://doaj.org/article/b54c6d6eecc34def8aa590eb17e2d625
Autor:
Juan V. Mulet Bayona, Nuria Tormo Palop, Carme Salvador García, Paz Herrero Rodríguez, Vicente Abril López de Medrano, Carolina Ferrer Gómez, Concepción Gimeno Cardona
Publikováno v:
Antibiotics, Vol 9, Iss 9, p 558 (2020)
The multi-resistant yeast Candida auris has become a global public health threat because of its ease to persist and spread in clinical environments, especially in intensive care units. One of the most severe manifestations of invasive candidiasis is
Externí odkaz:
https://doaj.org/article/1215824b650e4caa9b9d6b7f69cc4921
Autor:
Juan V Mulet Bayona, Manuel Belda Álvarez, Mercedes García, Nuria Tormo Palop, María del Remedio Guna Serrano, Carme Salvador García, Concepción Gimeno Cardona, David Navalpotro Rodríguez
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 38:39-44
Resumen Candida auris es una levadura multirresistente emergente que causa infecciones invasivas graves y brotes con una alta mortalidad. El control de C . auris es un reto. Laboratorios, clinicos e instituciones sanitarias deben trabajar conjuntamen
Autor:
Juan Vicente, Mulet Bayona, Carme, Salvador García, Nuria, Tormo Palop, Amparo, Valentín Martín, Carmelo, González Padrón, Javier, Colomina Rodríguez, Javier, Pemán, Concepción, Gimeno Cardona
Publikováno v:
Journal of fungi (Basel, Switzerland). 8(3)
Epidemiological trends show a dramatic increase in the prevalence of fungal infections, and in the isolation of multidrug-resistant species, such as
Autor:
Concepción Gimeno-Cardona, Juan Vicente Mulet-Bayona, Nuria Tormo-Palop, Carme Salvador-García
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 40:334-335
Autor:
Juan Vicente Mulet-Bayona, Carme Salvador-García, Nuria Tormo-Palop, Concepción Gimeno-Cardona
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 40:334-335
Publikováno v:
MycosesREFERENCES. 64(6)
Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics, England) is a real-time PCR assay approved for detecting C. auris in fungal cultures as well as directly from
Publikováno v:
Diagnostic microbiology and infectious disease. 98(4)
A shift to Candida non-albicans infections has been noted during the last years, and the emergence of multi-resistant Candida auris has complicated their management. The aim of this study was first to compare the performance of the novel chromogenic
Autor:
Carme Salvador, García, Nuria Tormo, Palop, Juan Vicente Mulet, Bayona, Mercedes Melero, García, David Navalpotro, Rodríguez, Manuel Belda, Álvarez, María Del Remedio Guna, Serrano, Concepción Gimeno, Cardona
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 38
Candida auris is an emerging multidrug-resistant yeast that causes serious invasive infections and outbreaks with high mortality. Controlling C. auris is a challenge in which laboratories, clinicians and public health agencies are needed to identify